Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications
NCT ID: NCT03052686
Last Updated: 2017-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2000-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uterine Rupture International Data Acquisition
NCT03576950
Outcomes of Uterine Rupture
NCT02878226
Prediction of Uterine Atony After Vaginal Delivery by Elastography
NCT04267783
The Effect of Placental Cord Drainage on Postpartum Blood Loss
NCT05610345
PDIUC Protocol for Placental Accreta
NCT03273569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The incidence of uterine rupture increases with increasing cesarean rates. It occurs at a rate of 0.08% across all childbirths in France, and 0.5 to 1% of the childbirths on cicatricial uterus in France.
Although the risk factors are known, it is usually unexpected. This is a serious complication for the mother (mortality \<1%, severe morbidity at 15% ) and for the child (mortality for 3 to 6 % for childbirth at term, neonatal asphyxia for 6 to 15%) that can occur during pregnancy or during labor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Childbirth with uterine rupture
No intervention. Follow-up of women with uterine rupture at the childbirth.
Childbirth with uterine rupture
No intervention. Follow-up of women with rupture uterine at the childbirth.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Childbirth with uterine rupture
No intervention. Follow-up of women with rupture uterine at the childbirth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MARKOU Georges, PH
Role: PRINCIPAL_INVESTIGATOR
CH Rene Dubos, Pontoise
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD0914
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.